[1]CurrentPatentAssignee:LGCHEMCO.,LTD.-US6818771,2004,B1Locationinpatent:Pagecolumn2-3
[2]CurrentPatentAssignee:LGCHEMCO.,LTD.-WO2004/92129,2004,A1Locationinpatent:Page17-18
[3]CurrentPatentAssignee:LGCHEMCO.,LTD.-US6703512,2004,B1Locationinpatent:Pagecolumn5
[1]CurrentPatentAssignee:LGCHEMCO.,LTD.-WO2003/87100,2003,A1Locationinpatent:Page/Pagecolumn13-14
[1]CurrentPatentAssignee:ORCHIDPHARMALTD-WO2008/53324,2008,A1Locationinpatent:Page/Pagecolumn12
[2]CurrentPatentAssignee:ORCHIDPHARMALTD-WO2008/53324,2008,A1Locationinpatent:Page/Pagecolumn11-12
Title: Hansen GT, ET AL. Mutant prevention concentration of gemifloxacin for clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother. 2003 Jan;47(1):440-1.
Title: Goldstein EJ, et al. In vitro activity of gemifloxacin (SB 265805) against anaerobes. Antimicrob Agents Chemother. 1999 Sep;43(9):2231-5.